PARD6B Inhibitors
PARD6B inhibitors belong to a distinct class of chemical compounds designed to modulate the activity of the protein Par-6 family cell polarity regulator beta (PARD6B). PARD6B is a critical component of the Par complex, a protein assembly involved in the establishment and maintenance of cell polarity in various tissues and cell types. Cell polarity is essential for a wide range of biological processes, including cell migration, tissue development, and organogenesis. PARD6B inhibitors are specifically designed to interfere with the function of PARD6B, which in turn affects the organization of cellular structures and cell-cell interactions.
The mechanism of action of PARD6B inhibitors primarily involves targeting the PARD6B protein itself or its associated protein-protein interactions. These inhibitors can disrupt the binding of PARD6B to its partner proteins, such as aPKC (atypical protein kinase C), Par-3, and Par-1, thereby perturbing the overall Par complex and, consequently, cell polarity. By doing so, PARD6B inhibitors offer researchers valuable tools to investigate the fundamental cellular processes that rely on proper cell polarity establishment, such as embryonic development, tissue homeostasis, and wound healing. Additionally, the study of PARD6B inhibitors may shed light on avenues in the future, given the crucial role of cell polarity in various disease states, including cancer metastasis and tissue regeneration.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, 5-Azacytidine may alter the methylation status of the PARD6B gene, potentially leading to changes in its expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This histone deacetylase inhibitor could influence chromatin structure and gene accessibility, potentially affecting PARD6B expression. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor, Staurosporine may inhibit kinases involved in signaling pathways that regulate PARD6B expression or activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
As a phosphatase inhibitor, Okadaic Acid could influence dephosphorylation events, potentially modulating PARD6B function. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
A small molecule inhibitor of BET bromodomains, JQ1 might modulate transcription factors or co-factors involved in the regulation of PARD6B expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that could potentially increase the stability of proteins negatively regulating PARD6B, leading to decreased PARD6B activity. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
A CDK4/6 inhibitor, PD 0332991 may affect cell cycle progression and indirectly influence PARD6B expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3 kinase inhibitor, LY294002 could modulate signaling pathways upstream of PARD6B, potentially affecting its expression or activity. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
By inhibiting the Hedgehog signaling pathway, Cyclopamine may indirectly affect the expression or activity of PARD6B. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, Rapamycin might modulate various cellular processes, potentially influencing PARD6B expression or activity. | ||||||